Gainers
-
Constellation Brands, Inc. (NYSE: STZ) rose 5.1
percent to $193.00 in pre-market trading after the company reported better-than-expected earnings for its first quarter and
raised its FY18 adjusted earnings outlook.
-
Spherix Inc (NASDAQ: SPEX) rose 34.6 percent to
$2.57 in pre-market trading after surging 70.54 percent on Wednesday.
-
Energous Corp (NASDAQ: WATT) shares rose 7.2
percent to $16.50 in pre-market trading after the company disclosed that Dialog Semiconductor is investing an additional $15
million in the company.
-
LG Display Co Ltd. (ADR) (NYSE: LPL) shares rose 7.2
percent to $17.85 in pre-market trading after declining 0.72 percent on Wednesday.
-
China Natural Resources Inc (NASDAQ: CHNR) rose
7.2 percent to $2.27 in pre-market trading after climbing 7.52 percent on Wednesday.
-
Affimed NV (NASDAQ: AFMD) shares rose 7 percent
to $2.30 in pre-market trading after gaining 2.38 percent on Wednesday.
-
Progress Software Corporation (NASDAQ: PRGS) rose
6.6 percent to $32.85 in pre-market trading after the company posted upbeat Q2 earnings and raised its FY17 outlook.
-
DelMar Pharmaceuticals Inc (NASDAQ: DMPI) shares
rose 6 percent to $2.50 in the pre-market trading session after surging 17.41 percent on Wednesday.
-
Walgreens Boots Alliance Inc (NASDAQ: WBA) rose
5.2 percent to $81.05 in pre-market trading. Rite Aid Corporation confirmed a finalized asset purchase agreement with rival
Walgreens. Walgreens has attempted to acquire the entirety of Rite Aid since 2015, but instead Rite Aid will now sell 2,186 of
its stores, related distribution assets and inventory for an all-cash purchase price of $5.175 billion. Walgreens also posted
upbeat quarterly earnings.
-
HSBC Holdings plc (ADR) (NYSE: HSBC) gained 4.8
percent to $46.79 after gaining 1.22 percent on Wednesday.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
-
Rite Aid Corporation (NYSE: RAD) shares fell 21.6
percent to $3.08 in pre-market trading. Rite Aid Corporation confirmed a finalized asset purchase agreement with rival
Walgreens. Walgreens has attempted to acquire the entirety of Rite Aid since 2015, but instead Rite Aid will now sell 2,186 of
its stores, related distribution assets and inventory for an all-cash purchase price of $5.175 billion. Walgreens also posted
upbeat quarterly earnings.
-
Fred's, Inc. (NASDAQ: FRED) fell 19.7 percent to
$9.89 in pre-market trading after after RiteAid and Walgreens announced termination of original divestiture agreement. Fred's
confirmed in a press release that all asset purchase agreements has been terminated and it will receive $25 million as
reimbursement for expenses associated with the termination.
-
VirnetX Holding Corporation (NYSE: VHC) shares fell
12 percent to $4.40 in pre-market trading after surging 3.09 percent on Wednesday.
-
Moleculin Biotech Inc (NASDAQ: MBRX) shares fell
11.9 percent to $2.89 in pre-market trading after surging 65.66 percent on Wednesday.
-
Pier 1 Imports Inc (NYSE: PIR) shares fell 9.9
percent to $4.85. Pier 1 Imports reported a narrower-than-expected loss for its first quarter, but revenue missed estimates.
-
Akebia Therapeutics Inc (NASDAQ: AKBA) fell 7.4
percent to $14.35 in pre-market trading. Akebia priced 4 million share offering at $14.50 per share.
-
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) fell
7.1 percent to $ 2.11 in pre-market trading after rising 8.61 percent on Wednesday.
-
Physicians Realty Trust (NYSE: DOC) shares fell 6.1
percent to $20.28 in pre-market trading. Physicians Realty Trust reported an offering of 20 million shares of common stock.
-
CGG SA (ADR) (NYSE: CGG) fell 6 percent to $4.40 in
pre-market trading after rising 4.00 percent on Wednesday.
-
Ominto Inc (NASDAQ: OMNT) shares fell 5.8 percent
to $10.99 in the pre-market trading session after climbing 6.48 percent on Wednesday.
-
HB Fuller Co (NYSE: FUL) fell around 5 percent to
$51.00 in pre-market trading after the company posted downbeat quarterly earnings.
-
Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) fell
3.3 percent to $12.89 in pre-market trading after gaining 1.37 percent on Wednesday.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.